Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
intravenous |
| gptkbp:ATCCode |
L01AA01
|
| gptkbp:brand |
gptkb:cyclophosphamide
|
| gptkbp:CASNumber |
50-18-0
|
| https://www.w3.org/2000/01/rdf-schema#label |
Endoxan
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Baxter
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:sideEffect |
nausea
hair loss bone marrow suppression |
| gptkbp:usedFor |
gptkb:cancer
immunosuppression |
| gptkbp:bfsParent |
gptkb:cyclophosphamide
|
| gptkbp:bfsLayer |
6
|